Amprenavir: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>David E. Volk
(Chem infobox)
imported>David E. Volk
m (ditto)
Line 3: Line 3:
{{Chem infobox
{{Chem infobox
|align=right
|align=right
|image=[[Image:Amprenavir structure.jpg|right|thumb|200px|{{#ifexist:Template:Amprenavir structure.jpg/credit|{{Amprenavir structure.jpg/credit}}<br/>|}}Amprenavir.]]  
|image=[[Image:Amprenavir structure.jpg|center|thumb|200px]]  
|width=200px
|width=200px
|molname=amprenavir
|molname=amprenavir

Revision as of 15:43, 26 March 2008

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.
Amprenavir structure.jpg
amprenavir
IUPAC name: see chemistry section
Synonyms: AMP, AMV, APV, VX-478
Formula: C25H35N3O6S

 Uses: HIV

 Properties: protease inhibitor

 Hazards: see drug interactions

Mass (g/mol): CAS #:
505.6269 161814-49-9



Amprenavir, also called AMP, AMV, APV and VX-478, is a protease inhibitor used to treat HIV infection. Protease inhibitors block HIV-1 protease, an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. Its IUPAC chemical name is [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3- hydroxy-1-phenylbutan-2-yl]carbamate.

Brand Names

  • Agenerase®
  • Prozei®
  • Vertex®

External Links